|Videos|November 22, 2022
PharmExec Interviews Christophe Bourdon at Pharma 2022
Advertisement
In this video, Christophe Bourdon, CEO, LEO Pharma highlights his keynote presentation to the Pharma 2022 audience, where he describes his recent leadership at LEO Pharma and how he is moving to deploying and redeploying resources in an agile way, as well as what patient centricity from a dermatology standpoint means.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5